According to the role of MALAT1 in worsening tumor progression, we have shown that WTAP expression levels significantly correlate with the worst clinical outcome shortening the overall survival and disease-free survival, identifying WTAP as a new effector of MALAT1. This evidence concerns the gene MALAT1 and neoplasm.